Prefer to watch? Click the video above.
Frontal Fibrosing Alopecia (FFA)
Frontal Fibrosing Alopecia (FFA) is a type of scarring alopecia that has become increasingly common in recent years.
Here's what you need to know:
What Is It?
FFA is a form of scarring alopecia where the hair follicles are permanently damaged, leading to irreversible hair loss. It primarily affects the front hairline and can cause the loss of eyebrows as well.
Rapid Increase in Cases:
Initially considered rare, with only the occasional case being recorded in the early 90s (first reported in 1994), FFA is now being diagnosed much more frequently. Clinics now report seeing multiple patients daily with this condition.
Who Is Affected?
While it was initially observed mainly in post-menopausal women, there has been a noticeable increase in cases among men and younger women in recent years. This has prompted further research to better understand the condition’s causes.
Possible Causes:
There is a suspected link between hormonal changes, especially in post-menopausal women, and the onset of FFA. However, the fact that younger women and men are now also being diagnosed suggests that other factors may be at play, and ongoing studies are investigating these potential causes.
Symptoms to Watch For:
Receding front hairline.
Thinning eyebrows or the complete loss of eyebrow hair.
Scalp inflammation and discomfort.
Treatment Options:
FFA is a scarring condition, which means that once the hair follicles are destroyed, they cannot regrow hair. Treatment focuses on stopping the progression of the disease to prevent further hair loss.
It's crucial to consult with a trichologist or dermatologist as soon as you notice symptoms to receive a diagnosis and start appropriate treatment.
Early Diagnosis Is Key:
Early intervention is vital to halt the progression of FFA. If you're experiencing hairline recession or eyebrow thinning, it's essential to seek professional advice for potential treatment options.
Think you may have hair loss? Consider booking in an online or in person consultation with us.
Comments